Forecasting COVID-19 confirmed cases, deaths and recoveries: Revisiting established time series modeling through novel applications for the USA and Italy E Gecili, A Ziady, RD Szczesniak PloS one 16 (1), e0244173, 2021 | 57 | 2021 |
Influences of environmental exposures on individuals living with cystic fibrosis R Szczesniak, JL Rice, C Brokamp, P Ryan, T Pestian, Y Ni, ... Expert review of respiratory medicine 14 (7), 737-748, 2020 | 27 | 2020 |
Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection D Hayes Jr, RK Shukla, Y Cheng, E Gecili, MR Merling, RD Szczesniak, ... JCI insight 7 (12), 2022 | 7 | 2022 |
Functional data analysis and prediction tools for continuous glucose-monitoring studies E Gecili, R Huang, JC Khoury, E King, M Altaye, K Bowers, ... Journal of Clinical and Translational Science, 1-10, 2020 | 7 | 2020 |
Lung function decline in cystic fibrosis: impact of data availability and modeling strategies on clinical interpretations R Szczesniak, ER Andrinopoulou, W Su, PM Afonso, PR Burgel, ... Annals of the American Thoracic Society 20 (7), 958-968, 2023 | 4 | 2023 |
Bayesian regularization for a nonstationary Gaussian linear mixed effects model E Gecili, S Sivaganesan, O Asar, JP Clancy, A Ziady, RD Szczesniak Statistics in Medicine, 2022 | 4 | 2022 |
Sweat metabolomics before and after intravenous antibiotics for pulmonary exacerbation in people with cystic fibrosis FW Woodley, E Gecili, RD Szczesniak, CL Shrestha, CJ Nemastil, ... Respiratory medicine 191, 106687, 2022 | 4 | 2022 |
An empirical comparison of segmented and stochastic linear mixed effects models to estimate rapid disease progression in longitudinal biomarker studies W Su, E Gecili, X Wang, RD Szczesniak Statistics in biopharmaceutical research 13 (3), 270-279, 2021 | 4 | 2021 |
Seasonal variation of lung function in cystic fibrosis: longitudinal modeling to compare a Midwest US cohort to international populations E Gecili, C Brokamp, A Palipana, R Huang, ER Andrinopoulou, T Pestian, ... Science of The Total Environment 776, 145905, 2021 | 3 | 2021 |
Cystic fibrosis point of personalized detection (cfpopd): An interactive web application C Wolfe, T Pestian, E Gecili, W Su, RH Keogh, JP Pestian, M Seid, ... JMIR medical informatics 8 (12), e23530, 2020 | 3 | 2020 |
Built environment factors predictive of early rapid lung function decline in cystic fibrosis E Gecili, C Brokamp, E Rasnick, PM Afonso, ER Andrinopoulou, ... Pediatric pulmonology 58 (5), 1501-1513, 2023 | 2 | 2023 |
Feedback at the Point of Care to Decrease Medication Alert Rates in an Electronic Health Record PJ Van Camp, ES Kirkendall, PA Hagedorn, T Minich, M Kouril, ... Pediatric Emergency Care 36 (7), e417-e422, 2020 | 2 | 2020 |
Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis AK Palipana, E Gecili, S Song, SR Johnson, RD Szczesniak, N Gupta Chest 163 (6), 1458-1470, 2023 | 1 | 2023 |
BODY COMPOSITION AND FUNCTIONAL CORRELATES OF CF YOUTH EXPERIENCING PULMONARY EXACERBATION AND RECOVERY T Boat, E Hente, W Hardie, R Szczesniak, E Gecili, G Zhou, J Taylor, ... Pediatric Pulmonology, 2022 | 1 | 2022 |
43: Monitoring and phenotyping rapid cystic fibrosis disease progression using community characteristics and environmental exposures A Palipana, E Gecili, C Brokamp, E Rasnick, A Vancil, D Ehrlich, T Pestian, ... Journal of Cystic Fibrosis 20, S22, 2021 | 1 | 2021 |
Seasonality, mediation and comparison (SMAC) methods to identify influences on lung function decline E Gecili, A Palipana, C Brokamp, R Huang, ER Andrinopoulou, T Pestian, ... MethodsX 8, 101313, 2021 | 1 | 2021 |
Body composition of patients with CF at the time of pulmonary exacerbation T Boat, E Hente, S Wang, J Taylor, S Summers, RD Szczesniak, E Gecilli, ... PEDIATRIC PULMONOLOGY 54, S254-S254, 2019 | 1 | 2019 |
Characterizing socioeconomic deprivation, climate and high traffic pollution improves prediction of lung-function trajectories RD Szczesniak, C Brokamp, P Ryan, Y Ni, E Andrinopoulou, RH Keogh, ... PEDIATRIC PULMONOLOGY 54, S233-S234, 2019 | 1 | 2019 |
Evaluating Precision Medicine Tools in Cystic Fibrosis for Racial and Ethnic Fairness SP Colegate, A Palipana, E Gecili, RD Szczesniak, C Brokamp Journal of Clinical and Translational Science, 1-24, 2024 | | 2024 |
Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapy GC Zhou, Z Wang, AK Palipana, ER Andrinopoulou, P Miranda Afonso, ... Respiratory Research 25 (1), 187, 2024 | | 2024 |